Medication info

Nutriflex 48 Injection

Prescription medicationSolutionIntravenous injectionApproval withdrawn
Ingredient · strength
L-Isoleucine›2.82gL-Leucine›3.76gL-Lysine Hydrochloride›3.41gL-Methionine›2.35gL-Phenylalanine›4.21gL-Threonine›2.18gL-Tryptophan›0.68gL-Valine›3.12gL-Arginine-L-Glutamate›5.98gL-Glutamic Acid›1.47gL-Histidine Hydrochloride›2.03gL-Alanine›5.82gL-Aspartic Acid›1.8gGlycine›1.98gL-Proline›4.08gL-Serine›3.6gMonobasic Sodium Phosphate Dihydrate›3.12gMagnesium Acetate Tetrahydrate›1.23gSodium Acetate Hydrate›1.56gPotassium Hydroxide›1.4gSodium Hydroxide›0.23gGlucose Monohydrate›Strength being verifiedCalcium Chloride›0.53g
Manufacturer / importer
B.Braun Korea Co., Ltd
Appearance
A clear liquid (mix of liquid A and B) filled in a transparent plastic container made of polyamide II (outer casing) and polypropylene (inner casing) with a light yellow color.
Packaging
Bag - 1000 milliliters/Bag
Approval status
Approval withdrawn

MFDS item code 200410468 · Notified 2004.10.25 · Insurance code 667400020

This product's status changed to Approval withdrawn on 2024.05.13. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of nutritional status in hypoproteinemia and malnutrition, and before and after surgery
Who receives it
Adults · Children
Adult administration
○ Adults: The maximum dose is 1~1.5 g of total amino acids/kg body weight per day. A concentration of approximately 10 g of total amino acids infused over 60 minutes is preferred. ○ Infusion rate: Administer by drip infusion at 25~30 drops per minute. This product should generally be administered via a central vein.
Child administration
For children, older adults, and patients with burns who have high protein requirements, adjust the dose and infusion rate as appropriate.

Ingredients

Importer
B.Braun Korea Co., Ltd

Efficacy & effects

Improvement of nutritional status in hypoproteinemia and malnutrition, and before and after surgery

  • Hypoalbuminemia
  • malnutrition
View approved original text

In cases of hypoalbuminemia, malnutrition, and conditions before and after surgery, the supply of amino acids and sugars is crucial. These nutrients are essential for protein synthesis and energy supply in the body, aiding in recovery of bodily functions and strengthening immunity. Sufficient supply of amino acids and sugars is necessary to improve and assist in recovery from these conditions.

How it is given

Adult administration

○ Adults: The maximum dose is 1~1.5 g of total amino acids/kg body weight per day. A concentration of approximately 10 g of total amino acids infused over 60 minutes is preferred. ○ Infusion rate: Administer by drip infusion at 25~30 drops per minute. This product should generally be administered via a central vein.

Child administration

For children, older adults, and patients with burns who have high protein requirements, adjust the dose and infusion rate as appropriate.

Precautions

This medication must be used strictly according to a physician's instructions. It should not be mixed with other medications containing calcium, such as ceftriaxone, when administered intravenously. Using the same infusion device for simultaneous administration may lead to the formation of dangerous precipitates. This medication should not be administered to patients with severe liver dysfunction or hepatic coma, patients with severely impaired kidney function, or patients with severe heart failure or pulmonary edema. Additionally, it is safe not to use in cases of hypernatremia, atrioventricular block, myasthenia gravis, metabolic acidosis, and diabetic complications excluding hypoglycemia, as well as in infants. Careful administration is required for patients with heart failure, kidney failure, liver dysfunction, pancreatic disorders, diabetes, dehydration, etc., and the patient's condition should be closely monitored during administration. Various adverse reactions such as acidosis, hypersensitivity reactions, gastrointestinal symptoms, palpitations, elevated blood pressure, chills, fever, vascular pain, headache, peripheral vascular dilation, hypophosphatemia, alkalosis, hyperglycemia, osmotic diuresis, dehydration, rebound hypoglycemia, elevated liver enzymes, vitamin deficiencies, vitamin excess, electrolyte imbalances, hyperammonemia in children, intolerance reactions, osmotic diuresis, and dizziness may occur during the administration of this medication, so caution is needed. Particularly, when administered rapidly in large volumes, serious side effects such as acidosis or hyperazotemia may occur, so the infusion rate should be adjusted. This medication can affect blood sugar, electrolytes, and acid-base balance, so regular monitoring and management of blood sugar and electrolyte status are required. Excessive fluid supply should be avoided in patients with kidney, lung, or heart disease, and diabetic patients should monitor blood sugar levels frequently. During pregnancy, safety has not been established, so it should only be administered under a physician’s judgment when absolutely necessary. It should not be used in infants and it is preferable to use specially formulated amino acid preparations for pediatric patients. Elderly patients should have the infusion rate slowed and dosage adjusted due to decreased physiological function. In case of overdose, symptoms such as dizziness, nausea, osmotic diuresis may appear, and in severe cases, discontinuation of the medication and professional treatment is necessary. This medication is a hypertonic preparation and should only be administered slowly via central venous access, and strict aseptic conditions must be maintained during administration. When storing, keep it in a sealed container away from air and light at room temperature, and do not use expired products. The mixed solution is stable for 24 to 28 hours, so it must be used within this period.

Side effects

  • Somnolence
  • hypersensitivity
  • rash
  • nausea
  • vomiting
  • hypernitrogenemia
  • chest discomfort
  • palpitations
  • tachycardia
  • elevated blood pressure
Show 31 more
  • chills
  • fever
  • vascular pain
  • headache
  • dyspnea
  • respiratory arrest
  • shock
  • bronchoconstriction
  • urinary constriction
  • peripheral vascular dilation
  • hypophosphatemia
  • alkalosis
  • hyperglycemia
  • diabetes
  • osmotic diuresis
  • dehydration
  • rebound hypoglycemia
  • elevated liver enzymes
  • vitamin deficiency
  • vitamin excess
  • electrolyte imbalance
  • pediatric hyperammonemia
  • increased BUN
  • serum amino acid imbalance
  • systemic nitrogenemia
  • hyperammonemia
  • loss of perception
  • coma
  • intolerance reactions
  • osmotic diuresis
  • dizziness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to avoid exposure to air and light, and it should be kept in a cool place between 15 to 25 degrees. Proper storage will help maintain the effectiveness of the medication and prevent deterioration.

Appearance and packaging

Appearance

A clear liquid (mix of liquid A and B) filled in a transparent plastic container made of polyamide II (outer casing) and polypropylene (inner casing) with a light yellow color.

Package unit

Bag - 1000 milliliters/Bag

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.